Cargando…
COVID‐19 antibody screening with SARS‐CoV‐2 red cell kodecytes using routine serologic diagnostic platforms
BACKGROUND: The Coronavirus disease 2019 (COVID‐19) pandemic is having a major global impact, and the resultant response in the development of new diagnostics is unprecedented. The detection of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has a role in managing the...
Autores principales: | Nagappan, Radhika, Flegel, Willy A., Srivastava, Kshitij, Williams, Eleanor C., Ryzhov, Ivan, Tuzikov, Alexander, Galanina, Oxana, Shilova, Nadezhda, Sukhikh, Gennady, Perry, Holly, Bovin, Nicolai V., Henry, Stephen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014685/ https://www.ncbi.nlm.nih.gov/pubmed/33590501 http://dx.doi.org/10.1111/trf.16327 |
Ejemplares similares
-
Serologic screening of United States blood donors for Babesia microti using an investigational enzyme immunoassay
por: Levin, Andrew E., et al.
Publicado: (2016) -
Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay
por: Levin, Andrew E, et al.
Publicado: (2014) -
Evaluation of a new West Nile virus nucleic acid test for screening of blood donations
por: Stanley, Jean, et al.
Publicado: (2018) -
High prevalence of human T‐cell leukemia virus type‐1b genotype among blood donors in Gabon, Central Africa
por: Ramassamy, Jill‐Léa, et al.
Publicado: (2020) -
Duplex nucleic acid test for the detection of chikungunya and dengue RNA viruses in blood donations
por: Stramer, Susan L., et al.
Publicado: (2019)